Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives

S. N. Pandeya, V. Mishra, P. N. Singh and D. C. Rupainwar, Anticonvulsant activity of thioureido derivatives of acetophenone semicarbazones, Pharmacol. Res. 37 (1998) 17-22; DOI: 10.1006/phrs.1997.0250.10.1006/phrs.1997.0250Search in Google Scholar

A. Almasirad, S. A. Tabatabai and M. Faizi, Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles, Bioorg. Med. Chem. Lett. 14 (2004) 6057-6059; DOI: 10.1016/j.bmcl.2004.09.072.10.1016/j.bmcl.2004.09.072Search in Google Scholar

H. N. Dogan, A. Duran, S. Rollas and G. Sener, Synthesis of new 2,5-disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities, Bioorg. Med. Chem. 10 (2002) 2893-2898; DOI: 10.1016/S0968-0896(02)00143-8.10.1016/S0968-0896(02)00143-8Search in Google Scholar

G. S. Singh, N. Siddiqui and S. N. Pandeya, Synthesis and anticonvulsant and anti-inflammatory activities of new 3-aryl/alkylimino-1-methylindol-2-ones, Arch. Pharm. Res. 15 (1992) 272-274.10.1007/BF02974069Search in Google Scholar

G. S. Singh, N. Siddiqui and S. N. Pandeya, Synthesis and anticonvulsant activity of 3-aryl/alkyl iminoindol-2-ones, Asian J. Chem. 5 (1993) 788-791.Search in Google Scholar

Z. Y. Zhang, X. W. Sun and H. T. Liang, Synthesis and antibacterial activity of 4-aryl-1-(1-p-chlorophenyl-5-methyl-1,2,3-triazol-4-carbonyl)thiosemicarbazides and their related heterocyclic derivatives, Indian J. Chem.38B (1999) 679-683.Search in Google Scholar

R. I. Krall, J. K. Penry, B. G. White, H. J. Kupferberg and E. A. Swingard, Antiepileptic drug development II. Anticonvulsant drug screening, Epilepsia 19 (1978) 409-428; DOI: 10.1111/j.1528-1157.1978.tb04507.x.10.1111/j.1528-1157.1978.tb04507.xSearch in Google Scholar

R. J. Porter, J. J. Cereghiao, G. D. Gladding, B. J. Hessie and B. White, Antiepileptic drug development program, Cleveland Clin. Quart. 51 (1984) 293-305.10.3949/ccjm.51.2.293Search in Google Scholar

J. P. Stables and H. J. Kupferberg, The NIH Anticonvulsant Drug Development (ADD) Program: Preclinical Anticonvulsant Screening Project, in Molecular and Cellular Targets for Anti-epileptic Drugs (Eds. G. Avanzini, G. Regesta, P. Tanganelli and M. Avoli), John Sibbey, London 1997, pp. 191-198.Search in Google Scholar

I. Kucukguzel, S. G. Kucukguzel, S. Rollas, O. Ozdemir, I. Bayrak and J. P. Stables, Synthesis of some 3-(aryl/alkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity, Farmaco 59 (2004) 893-901; DOI: 10.1016/j.farmac.2004.07.005.10.1016/j.farmac.2004.07.005Search in Google Scholar

Antiepileptic Drugs (Eds. H. S. White, H. Woodhead, M. R. Franklin, R. H. Levy, R. H. Mattson and B. S. Meldrum), Raven, New York 1995, p. 99.Search in Google Scholar

J. R. Dimmock, S. N. Pandeya, J. W. Quail, U. Pugazhenthi, T. M. Allen and G. Y. Kao, Evaluation of the semicarbazones, thiosemicarbazones and bis-carbohydrazones of some aryl alicyclic ketones for anticonvulsant and other biological properties, Eur. J. Med. Chem. 30 (1995) 303-314; DOI: 10.1016/0223-5234(96)88238-9.10.1016/0223-5234(96)88238-9Search in Google Scholar